ResearcherSichuan UniversityNo recent work listed

Xiaoxiao Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0006-8369-0570; OpenAlex author ID A5100694730. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper

Papers 2

Co-delivery of autophagy inhibitor and gemcitabine using a pH-activatable core-shell nanobomb inhibits pancreatic cancer progression and metastasis. Co-author DOI 10.7150/thno.60437 ↗
Knockdown of hypoxia-inducible factor-1 alpha by tumor targeted delivery of CRISPR/Cas9 system suppressed the metastasis of pancreatic cancer. Co-author DOI 10.1016/j.jconrel.2019.05.019 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Miao Deng · 2 shared papers, 2019–2021 · strength 0.20
- Paper Co-delivery of autophagy inhibitor and gemcitabine using a pH-activatable core-shell nanobomb inhibits pancreatic cance… DOI 10.7150/thno.60437 ↗
- Paper Knockdown of hypoxia-inducible factor-1 alpha by tumor targeted delivery of CRISPR/Cas9 system suppressed the metastasi… DOI 10.1016/j.jconrel.2019.05.019 ↗
Zhirong Zhang · 2 shared papers, 2019–2021 · strength 0.20
- Paper Co-delivery of autophagy inhibitor and gemcitabine using a pH-activatable core-shell nanobomb inhibits pancreatic cance… DOI 10.7150/thno.60437 ↗
- Paper Knockdown of hypoxia-inducible factor-1 alpha by tumor targeted delivery of CRISPR/Cas9 system suppressed the metastasi… DOI 10.1016/j.jconrel.2019.05.019 ↗
Man Li · 2 shared papers, 2019–2021 · strength 0.20
- Paper Co-delivery of autophagy inhibitor and gemcitabine using a pH-activatable core-shell nanobomb inhibits pancreatic cance… DOI 10.7150/thno.60437 ↗
- Paper Knockdown of hypoxia-inducible factor-1 alpha by tumor targeted delivery of CRISPR/Cas9 system suppressed the metastasi… DOI 10.1016/j.jconrel.2019.05.019 ↗
Qin He · 2 shared papers, 2019–2021 · strength 0.20
- Paper Co-delivery of autophagy inhibitor and gemcitabine using a pH-activatable core-shell nanobomb inhibits pancreatic cance… DOI 10.7150/thno.60437 ↗
- Paper Knockdown of hypoxia-inducible factor-1 alpha by tumor targeted delivery of CRISPR/Cas9 system suppressed the metastasi… DOI 10.1016/j.jconrel.2019.05.019 ↗
Qinglin Sheng · 1 shared paper, 2021 · strength 0.11
- Paper Co-delivery of autophagy inhibitor and gemcitabine using a pH-activatable core-shell nanobomb inhibits pancreatic cance… DOI 10.7150/thno.60437 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.